Amarin



Ebitda Endring Dato
AbbVie USD 6.92B 258M 2024-12
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amarin USD -24415000 24.65M 2024-09
AstraZeneca USD 5.08B 182M 2025-03
DBV Technologies USD -27409000 2.3M 2024-09
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12



Amarin - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.